| Literature DB >> 28546894 |
Michelle Romero-Franco1,2, Hilary A Godwin1,2,3,4, Muhammad Bilal1,3,4, Yoram Cohen1,3,4,5.
Abstract
The potential environmental impact of nanomaterials is a critical concern and the ability to assess these potential impacts is top priority for the progress of sustainable nanotechnology. Risk assessment tools are needed to enable decision makers to rapidly assess the potential risks that may be imposed by engineered nanomaterials (ENMs), particularly when confronted by the reality of limited hazard or exposure data. In this review, we examine a range of available risk assessment frameworks considering the contexts in which different stakeholders may need to assess the potential environmental impacts of ENMs. Assessment frameworks and tools that are suitable for the different decision analysis scenarios are then identified. In addition, we identify the gaps that currently exist between the needs of decision makers, for a range of decision scenarios, and the abilities of present frameworks and tools to meet those needs.Entities:
Keywords: engineered nanomaterials; environmental impacts; risk assessment
Year: 2017 PMID: 28546894 PMCID: PMC5433198 DOI: 10.3762/bjnano.8.101
Source DB: PubMed Journal: Beilstein J Nanotechnol ISSN: 2190-4286 Impact factor: 3.649
Figure 1Challenges encountered at each step of the traditional risk assessment process for conventional chemicals and its relevance to ENMs.
Summary of critical characteristics of existing risk assessment frameworks relevant to ENMs.
| Name of the framework and developer | General description | Main output of analysis |
| Swiss precautionary matrix [ | Decision tree/questionnaire about the ENM properties under consideration (e.g., dimensions), effects (e.g., reactivity, stability), and exposure/release potential (e.g., physical form of the ENM), suitable for pre-screening. | Classification of the hazard posed by the ENM into two main groups: A) no need for review of (unspecified) risk management measures; B) need for review of (unspecified) risk management measures or need for additional information. |
| Risk Classification System based on Multi Criteria Decision Analysis (MCDA risk classification) (various institutions) [ | Systematic comparison of alternatives (ENMs) via outranking by assigning scores (e.g., qualitative scale of least-most desirable (1–4), subjective probability (0–100%), and quantitative measurement of size (0–100)) for pre-determined criteria related to hazard, including intrinsic ENM properties (e.g., agglomeration, reactivity/charge, critical function groups, contaminant dissociation and size) and factors affecting toxicity (bioavailability and bioaccumulation). | Categorical classification of the hazard (e.g. |
| Hazard and exposure potential identification for ENMs in consumer products (NanoRiskCat) [ | Decision tree/flowchart, where user answers “yes”, “no”, or “no data” to questions about the ENM of interest (e.g., physical form of the ENM applied to products, toxicity evidence, high aspect ratio, potential of transport across ecosystems). | Color-coded/categorical classification of the hazard posed by the ENM: the scale ranges from a grey color assigned to insufficient data, green-low hazard, yellow-medium and red-high. |
| DF4Nano grouping [ | Theoretical framework presented in tables (e.g., threshold values obtained from published data and expert elicitation) to guide the user in the classification/prioritization of ENMs for additional testing/risk assessment. | Categorical classification of ENMs in four main categories: 1) soluble ENMs, 2) biopersistent high-aspect ratio (for which no additional testing is required), 3) passive ENMs, and 4) active ENMs (which require a further analysis/risk assessment). |
| Modified GreenScreen [ | Hazard assessment framework designed to screen chemicals based on a range of toxicity endpoints and ENM physicochemical properties. | Categorical classification of ENMs in 5 main categories of aggregated benchmark (BM) scores to designate specific recommendations regarding ENM use based on the potential environmental and human health concerns as supported by available data. |
| Life Cycle Analysis (LCA) [ | Class of approaches that follow a product over its life stages, including: (a) material acquisition and purification, (b) manufacturing and fabrication, (b) commercial uses, and (d) end-of-life product management. | Environmental impacts of the product under analysis (e.g., effects on ecological receptors, potential CO2 emissions attributed to synthesis/manufacture of ENMs). |
| DUPONT’s Nanorisk [ | Systematic collection and organization of information, that can include a chemical process risk assessment (CPQRA) following AICHE guidelines in cases where sufficient quantitative data are available. CPQRA focuses on acute rather than chronic hazards. Risk in this system is defined as a function of a hypothetical scenario, the estimated consequence(s) of exposure, and the estimated exposure frequency. | Results for individual ENMs and scenarios are presented as lifecycle profiles that include information on physicochemical properties, ecotoxicity, and environmental fate to be used for risk management strategies. In cases where quantitative data are available, the results include a quantitative risk analysis of the industrial processes related to the ENM. |
| US EPA’s Comprehensive Environmental Assessment CEA [ | Compilation of extensive information needed to inform a “collective judgment”. Experts must then analyze the information to provide guidance to decision makers such as research planners and risk managers. This framework is presented as a roadmap to guide the user in a systematic data collection and identification of critical data gaps. | Summary of available information regarding a specific ENM. Typically accompanied by an evaluation of the resulting information by a group of experts that provides recommendations for research priorities and risk management. |
| An Adaptive Screening-Level Life Cycle Risk-Assessment Framework for Nanotechnology (Nano LCRA) [ | Systematic compilation of information (e.g., properties, potential exposure and hazard of ENMs through all life cycle stages for a particular product) guided by a “roadmap” that is further analyzed by experts. | Summary of information with main findings/expert judgment based on those findings and indication of further information needs. |
| Ranking initial environmental and human health risk: Nano HAZ framework [ | Process for developing qualitative risk rankings, including ecological risk and/or human health risk, for ENMs. Risk rankings reflect Bench Mark Dose (BMD) calculations, which are based on published/available data. | Categorical classification of ENMs into relative risk ranking groups: 0–2 (low environmental or health risk on a relative basis), 3–4 (concentrations that require monitoring and potential action), 5 + (environmental concentration above those provisional regulatory and toxicological limits as set in this study). |
| Nanomaterial risk screening [ | The framework guides the user through the process of assigning risk groups to ENMs. The categories are determined based on comparisons between data for the ENM under analysis to a reference set of information (tables) provided by the framework. | Categorical classification of ENMs in risk groups, where lowest concern = 1 and highest concern = 5. |
| Engineered Nanoparticles – Review of Health and Environmental Safety: Human health and Ecological Risk Assessment (ENRHES RA) [ | Risk assessment of specific ENMs based on 90-day exposure studies and likely environmental concentrations determined by probabilistic models. | Ratio of the predicted environmental concentration for ENM of interested to the (predicted) concentration at which there is no effect (related to human health; PEC/INEC). |
| A risk quantification based on probabilistic mass flow analysis (PMFA risk quantification) [ | Risk assessment for ENM of interest that combines predicted environmental concentrations (determined via probabilistic modeling) with a species sensitivity distribution (e.g., probability distribution of harmful effects shown at different concentrations for a given ENM). | Quantitative measure of risk calculated from the product of the probability of critical environmental concentrations and the probability that organisms would potentially be negatively impacted by such concentrations. |
| Bayesian Networks based FINE (Forecasting the Impacts of Nanomaterials in the Environment applied to nanoAg) [ | Method for calculating the probability of risk for an ENM of interest using a Bayesian Network designed with inputs from expert judgment. | Modified version of a deterministic risk quotient (quantitative measure of risk) in a probabilistic expression. |
| Risk based classification for occupational exposure control (Risk based OEL) [ | Process for quantitatively assessing the risk associated with the ENM of interest by applying benchmark doses (BMD). | Percent excess risk related to a specific health outcome as a result of exposure to the ENM under analysis. |
| Risk classification based on an Industry Insurance Protocol (RCIP) [ | Comparison of scores assigned to characteristics of the target industrial process with pre-established scores from an insurance protocol. | Relative risk ranking for the ENM process compared to conventional industrial chemical process. |
| Control Banding: CB Nanotool [ | Classification based on characteristics of the potential for exposure during preparation the ENM of interest (e.g., estimated amount of ENMs, dustiness/mistiness, number of employees with similar exposure, frequency and duration of operation) and properties related to hazard of the ENM (e.g., surface chemistry, particle shape and diameter, solubility, carcinogenicity, reproductive toxicity, mutagenicity, dermal hazard potential). | Risk banding of occupational risks. The risk bands are intended for developing recommendations risk management strategies for exposure control (e.g., RL 1: general ventilation; RL 2: fume hoods or local exhaust ventilation; RL 3: containment; RL 4: seek advice of environmental health specialist). |
| Web-Based Tool for Risk Prioritization of Airborne Manufactured Nano Objects (Stoffenmanager Nano) [ | Classification based on the characteristics of the potential for exposure during preparation of the ENM of interest (ENM size, aspect ratio, handling, background exposure, duration, frequency) and properties related to hazard (e.g., toxicity) associated with the ENM. | Priority banding where the bands indicate the priorities for risk management. |
Decision needs and recommended ENMs relevant risk assessment frameworks for selected regulatory decision-making scenarios.
| Scenario | Example and desired output of analysis | Potential framework for use/ currently available frameworks |
| Scenario I: Company deciding whether to control exposure to workers during manufacturing or processing of ENMs. | A company is producing a new ENM and needs to identify the controls necessary to protect their workers. | Swiss Precautionary Matrix; DuPont NanoRisk [ |
| Internal risk management strategy including recommended engineering controls, administrative controls | ||
| Scenario II: Regulatory body deciding whether to control exposure to workers during manufacturing or processing. | OSHA deciding whether to establish Occupational Exposure Limits (OEL)/Permissible Exposure Limits (PEL) for a specific class of ENMs. | Risk based classification for occupational exposure control (Risk based OEL) [ |
| Evidence based recommendations or requirements for allowed exposure. | ||
| Scenario III: Company deciding whether risk associated with producing a nanoparticle or nano-enabled product is manageable. | Company needs to assess the potential impacts of the production of a nano-enabled product and how to manage risks if any. | Web-Based Tool for Risk Prioritization of Airborne Manufactured Nano Objects (Stoffenmanager Nano) [ |
| Risk assessment of a particular ENM and risk management strategy. | ||
| Scenario IV: Company deciding which nanoparticle or nano-enabled product poses less risk than alternatives for a particular application. | Company interested in a precautionary approach for safe-by-design applications. | Multi-criteria Decision Analysis (MCDA) [ |
| Assessment or comparison of alternatives in terms of environmental impacts and technical performance. | ||
| Scenario V: Regulatory body deciding whether to control environmental use, release, or emissions of an ENM. | US EPA deciding whether to issue a Significant New Use Rule (SNUR) under TSCA (Toxic Substances Control Act) for a particular type of ENM. | US EPA’s Comprehensive Environmental Analysis (CEA) [ |
| Substantial evidence to indicate that a specific ENM will present an unreasonable risk to people or the environment. | ||
| Scenario VI: Regulatory body deciding whether to allow nanoparticles to be included in food, drugs, personal care products. | US FDA deciding whether to allow registration of a new nano-enabled product in food (whole food, dietary supplement, food ingredient or additive), medical devices, drugs or cosmetics. | NanoRiskCat [ |
Safety assessment for cosmetic products or a Risk Evaluation and Mitigation Strategy (REMS) for a new drug [30].